drugset / Trial / NCT00839007
Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of the study is to assess the safety and tolerability of IV administration of CD-NP and the dose relationship of CD-NP on improvement of clinical symptoms and renal function in ADHF patients.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cenderitide | Peptide | — | Intravenous |